Pharm for Hyperlipidemia Flashcards

1
Q

Zetia (Ezetimibe) COI MOA

A

Selective inhibition of cholesterol absorption by blocking transport at the brush order of the small intestine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Zetia (Ezetimibe) COI Therapeutic Effects

A

Decrease of LDL Levels
No effect on absorption of fat soluble vitamins, triglycerides or bile salts
Used alone and diet or in combo w/ statins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Zetia (Ezetimibe) COI Adverse Effect and Excretion

A

Flatulence
Diarrhea
Myalgia
Excreted primarily in feces

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Orlistat (Xenical, Alli) FAI MOA

A

Inhibitor of pancreatic lipase and decreases absorption of dietary fat by ~25%
Pancreatic Lipase is released into duodenum to break apart large fatty globules into free Fatty acids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Orlistat FAI Therapeutic Effects

A

Primarily used to treat obesity

additional effect to decrease LDL levels in obese patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Zetia ADME

A

Absorbed, glucouronidated and reexcreted in the gut. Plasma peak concerntration at 4 to 12 h
Zetia is systemic to a limited degree about 90% protein bound.
T1/2 is equal to 22 hours`

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Orlistat ADME

A

poorly absorbed systemically
stays in the gut
Minimal metabolism in the gut epithelium and microflora
Eliminated in feces

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Bile Acid Binding Resins MOA (Cholestyramine)

A

Bind bile acids
Bind negatively charged bile acids in the small intestine
Resin/bile acid complex is excreted in feces
Hepatocytes increase conversion of cholesterol to bile acid to compensate for loss
up regulate LDL Receptors to increase uptake of cholesterol and decrease plasma LDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Therapeutic effects of BABS

A

Moderate decrease in LDL levels, increasing HDL

Large Molecules, insoluble in water, not absorbed or metabolized will be excreted via feces

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Adverse Effects of BABS

A

GI effects: flatulence, constipation, diarrhea
Impaired absorption: may decrease fat soluble vitamin absorption
Drug interactions: Decrease absorption of many drugs
(tetracycline,phenobarbital, digoxin, warfarin, pravastatin, fluvastatin, aspirin and thiazides)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

BABSTherapeautic cautions/ Contraindications

A

Safe drug
Can be used during pregnancy without causing harm
Biliary stones or complete bilary obstruction: contraindicated if bile acid secretion is impaired

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

BABS ADME

A

A- not systemically absorbed
D-stays in the gut
M-not metabolized
E- Feces

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Niacin MOA

A

at gram doses, Strongly inhibit lipolysis of adipose tissue

utilizes circulating FA as precursors of triglycerol synthesis which is used in synthesis of VLDL and ultimately LDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Therapeutic Effects of Niacin

A

Lowers plasma levels of both cholesterol and triacylglycerol

The most effective antihyperlipidemic to raise plasma HDL Levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Niacin ADME

A
Peak plasma Concentrations
niacor~ 30 to 60 min
Niaspan ~ 5 h but varies
Broad systemic distribution
Rapid 1st pass metabolism
excreted mostly in urine and 12% as parent compound
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Adverse effects of Niacin

A

Primarly Intense Cutaneous Flush and Pruitis
N/V, abdominal pain
Inhibits tubular secretion of uric acid.
may impair glucose tolerance and caution w/ Diabetics
Hepatotoxicity

17
Q

Fibrates MOA

A

Increase LPL activity by activating PPARs which is a transcription factor for LPL synthesis.
LPL activity will decrease triacylglycerol levels by hydrolyzing triacylglycerols in chylomicrons and VLDL
Increase HDL levels

18
Q

Therapeutic effects of Fibrates

A

decrease triglyceride levels and Increase HDL cholesterol levels.
First line therapy to reduce risk of pancreatitis in patients with high plasma triglycerides.

19
Q

Adverse effects of fibrates

A
Mild GI disturbances 
Predisposition of gall stones 
hepatoxicity 
significant number of malignancy related deaths.
Myositis
Drug interactions
Contraindications
20
Q

Fibrate ADME

A

A: Lopid ~1 to2 h, Niaspan ~5 but highly variable
D: Broad systemic distribution, plasma bound
M: Rapid 1st pass
E: mostly glucouronidated in urine and less than 2% as parent compound. T1/2= 20 to 22 h

21
Q

Statin MOA

A

analogs HMG cholesterol precursor, Completley inhibits rate limiting enzyme in the synthesis of cholesterol
Depletion of intracellular cholesterol leads to elevated cellular LDL receptors to increase uptake from ciruclation
decreases cholesterol synthesis and increases catabolism of LDL

22
Q

Therapeutic uses of statins

A

Reduction of total and LDL cholesterol
first choice
may be useful in patients with or without CVD
Pleiotropic effects ( regression of plaque size increased endothelial function stablize platelets reduction of plasma fibrinogen Decrease inflammatory markers)

23
Q

Statin Adverse effects

A

Give warnings of myopathy and liver enzyme elevation

Hepatotoxicity is rare and muscle is rare and dose related

24
Q

When statins should be taken?

A

Atorvastatin and Rosuvastatin can be taken whenever

Simvastatin, lovastatin, fluvastatin, and lovastatin should be taken in the evening

25
Q

Pregnancy and Lipid lowering drugs

A

either totally or relatively contraindicated because essential role of cholesterol in fetal development
Bile acid resins should be used but do not use statins
woman desiring to become pregnant should stop statins 6 months before contraception